Theranostics highlighted in 2025 PSMA and Beyond Conference

UCLA, UCSF and the Prostate Cancer Foundation co-sponsored the recent 2025 PSMA and Beyond conference, held at the Luskin Center this past March. This event explored the latest theranostic advancements in PSMA (prostate-specific membrane antigen) PET imaging and radioligand therapies for prostate cancer.

Please see UCLA Health for the complete article. (Photo features event presenter and moderator, Dr. Jeremie Calais, a Pharmacology faculty member, in conversation with UCLA patient Kent Greer.)